C. Bánki

发表

Study on COgnition and Prognosis in the Elderly (SCOPE): Baseline Characteristics

A. Hofman, A. Zanchetti, V. Hachinski, 2000, Blood pressure.

Clinical observations with pizotifene (Sandomigran) in the treatment of nonmigrainous depressed women

C. Bánki, 1978, Archiv für Psychiatrie und Nervenkrankheiten.

Ph. D. dissertation INVESTIGATION OF ENDOGENOUS OPIOID REACTIVITY WITH FENTANYL CHALLENGE IN MAJOR DEPRESSION AND SELF-INJURIOUS BEHAVIOR

I. Bitter, Z. Rihmer, G. Faludi, 2005 .

Cerebrospinal fluid neuropeptides in mood disorder and dementia.

C. Nemeroff, G. Bissette, C. Bánki, 1992, Journal of affective disorders.

Biochemical markers in suicidal patients. Investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests.

C. Bánki, M. Arato, Z. Papp, 1984, Journal of affective disorders.

Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women

C. Bánki, 2005, Journal of Neural Transmission.

Hypothalamic‐Pituitary‐Adrenal Axis and Suicide

C. Nemeroff, G. Bissette, M. Aratô, 1986, Annals of the New York Academy of Sciences.

CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse

C. Nemeroff, G. Bissette, C. Bánki, 1992, European Neuropsychopharmacology.

Correlation between cerebrospinal fluid amine metabolites and psychomotor activity in affective disorders

C. Bánki, 1977, Journal of neurochemistry.

Dexamethasone suppression and multiple hormonal responses (TSH, prolactin and growth hormone) to TRH in some psychiatric disorders

M. Aratô, C. Bánki, Z. Papp, 2004, European archives of psychiatry and neurological sciences.

Associations among dexamethasone non-suppression and TRH-induced hormonal responses: increased specificity for melancholia

Z. Rihmer, C. Bánki, M. Arato, 1986, Psychoneuroendocrinology.

Thyroid stimulation test in healthy subjects and psychiatric patients

C. Bánki, M. Arato, Z. Papp, 1984, Acta psychiatrica Scandinavica.

Elevation of immunoreactive CSF TRH in depressed patients.

C. Nemeroff, G. Bissette, C. Bánki, 1988, The American journal of psychiatry.

Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: Study on COgnition and Prognosis in the Elderly (SCOPE)

A. Hofman, A. Zanchetti, V. Hachinski, 2005, Alzheimer's & Dementia.

Corticotropin-Releasing Factor in Depression and Suicide

C. Nemeroff, G. Bissette, M. Aratô, 1988 .

Biochemical Disturbances in Psychiatric Disorder: Are They Specific to Diagnosis or to Certain Symptoms?

M. Aratô, C. Bánki, Z. Papp, 1985 .

Metabolic Disturbances in Psychiatric Disorder: The Question of Diagnostic Specificity

M. Aratô, C. Bánki, Z. Papp, 1985 .

Amine metabolites, neuroendocrine findings, and personality dimensions as correlates of suicidal behavior

M. Aratô, C. Bánki, 1983, Psychiatry Research.

Amine metabolites and neuroendocrine responses related to depression and suicide.

C. Bánki, M. Arato, 1983, Journal of affective disorders.

Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 1. Background variables.

C. Bánki, G. Molnár, M. Vojnik, 1981, Journal of affective disorders.

Elevated CSF CRF in suicide victims

C. Nemeroff, G. Bissette, M. Aratô, 1989, Biological Psychiatry.

Aminergic Studies and Cerebrospinal Fluid Cations in Suicide

C. Kilts, M. Aratô, C. Bánki, 1986, Annals of the New York Academy of Sciences.

Cerebrospinal Fluid Amine Metabolites and Neuroendocrine Findings: Biochemical Markers in Suicide?

M. Aratô, C. Bánki, Z. Papp, 1985 .

Cerebrospinal fluid amine metabolites after combined amitriptyline-triiodothyronine treatment of depressed women

C. Bánki, 1977, European Journal of Clinical Pharmacology.

Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts

M. Aratô, C. Bánki, Z. Papp, 1985, Biological Psychiatry.

Correlation of individual symptoms and other clinical variables with cerebrospinal fluid amine metabolites and tryptophan in depression

I. Fekete, C. Bánki, G. Molnár, 2005, Archiv für Psychiatrie und Nervenkrankheiten.

Cerebrospinal fluid amine metabolites, tryptophan and clinical parameters in depression. Part 2. Psychopathological symptoms.

C. Bánki, G. Molnár, M. Vojnik, 1981, Journal of affective disorders.

CEREBROSPINAL FLUID 5-HIAA AS AN INDEX OF CENTRAL SEROTONERGIC PROCESSES

C. Bánki, G. Molnár, 1980 .

Cerebrospinal fluid 5-hydroxyindoleacetic acid as an index of central serotonergic processes

C. Bánki, G. Molnár, 1981, Psychiatry Research.

Comparative simultaneous measurement of cerebrospinal fluid 5-hydroxyindoleacetic acid and blood serotonin levels in delirium tremens and clozapine-induced delirious reaction.

C. Bánki, M. Vojnik, 1978, Journal of neurology, neurosurgery, and psychiatry.

CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia.

C. Nemeroff, G. Bissette, C. Bánki, 1987, The American journal of psychiatry.

Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence

C. Bánki, 2005, Journal of Neural Transmission.

The influence of age, height, and body weight on cerebrospinal fluid amine metabolites and tryptophan in women.

C. Bánki, G. Molnár, 1981, Biological psychiatry.

Parkinsonian symptoms with lithium, lithium-neuroleptic, and lithium-antidepressant treatment.

Z. Rihmer, C. Bánki, A. Perényi, 1983, Journal of affective disorders.

Multiple hormonal responses to morphine: Relationship to diagnosis and dexamethasone suppression

C. Bánki, M. Arato, 1987, Psychoneuroendocrinology.

Study on COgnition and Prognosis in the Elderly (SCOPE).

A. Hofman, A. Zanchetti, V. Hachinski, 1999, Blood pressure.

Differential changes of blood and urinary indoleamines following intravenous ethanol administration in alcoholic and non-drinker women

C. Bánki, M. Vojnik, 2005, Journal of Neural Transmission.

5‐Hydroxytryptamine content of the whole blood in psychiatric illness and alcoholism

C. Bánki, 1978, Acta psychiatrica Scandinavica.

Cerebrospinal fluid neuropeptides in dementia

C. Nemeroff, G. Bissette, C. Bánki, 1992, Biological Psychiatry.

The red blood cell/plasma lithium ratio: Marker of biological heterogeneity within bipolar affective illness?

Z. Rihmer, M. Aratô, C. Bánki, 1982, Psychiatry Research.

Prolactin response to fentanyl in depression

G. Bagdy, E. Frecska, M. Aratô, 1989, Biological Psychiatry.

Diurnal variation in fentanyl-induced hormone responses and side effects.

G. Bagdy, E. Frecska, M. Aratô, 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia

I. Bitter, Z. Janka, J. Füredi, 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

Cerebrospinal-fluid neuropeptides: a biochemical subgrouping approach.

C. Nemeroff, G. Bissette, C. Bánki, 1992, Neuropsychobiology.

A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study

G. L’italien, R. Kerwin, B. Millet, 2007, European Psychiatry.

Hungary: New horizons in psychiatry?

C. Bánki, 1991, The Lancet.

CSF corticotropin-releasing factor-like immunoactivity in chronic pain patients with and without major depression

K. Krishnan, R. France, B. Urban, 1988, Biological Psychiatry.

Serotonin: La chica de moda in biological psychiatry?

C. Bánki, 1991, Biological Psychiatry.

Cerebrospinal fluid amine metabolites in delirium tremens.

C. Bánki, G. Molnár, 1981, Psychiatria clinica.

Cerebrospinal fluid biochemical examinations: do they reflect clinical or biological differences?

C. Bánki, M. Arato, Z. Papp, 1983, Biological psychiatry.

CSF corticotropin releasing hormone, somatostatin, and thyrotropin releasing hormone in schizophrenia

C. Nemeroff, G. Bissette, C. Bánki, 1992, Psychiatry Research.

Cortisol response to morphine and the DST

M. Aratô, C. Bánki, 1985, Psychiatry Research.

Prophylactic potential of selective reuptake inhibitors in suicidal patients

C. Bánki, 1995, International Clinical Psychopharmacology.